306428833	306428833	CD	B-NP	O
|	|	NN	I-NP	O
ACMH	ACMH	NN	I-NP	O
|	|	NN	I-NP	O
46947625	46947625	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
075014	075014	CD	B-NP	O
|	|	CC	I-NP	O
2/16/1997	2/16/1997	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
UNSTABLE	UNSTABLE	NNP	I-NP	I-protein
ANGINA	ANGINA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/16/1997	2/16/1997	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/14/1997	9/14/1997	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
MYOCARDIAL	MYOCARDIAL	JJ	B-NP	O
INFARCTION	INFARCTION	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

SARCOIDOSIS	SARCOIDOSIS	NNS	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

HYPERTENSION	HYPERTENSION	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

NON-INSULIN-DEPENDENT	NON-INSULIN-DEPENDENT	JJ	B-NP	O
DIABETES	DIABETES	NNS	I-NP	O
MELLITUS	MELLITUS	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

STATUS	STATUS	NNP	B-NP	O
POST	POST	NNP	I-NP	O
PACEMAKER	PACEMAKER	NNP	I-NP	O
PLACEMENT	PLACEMENT	NNP	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
65-year-old	65-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
non-insulin-dependent	non-insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
exertional	exertional	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
characterized	characterize	VBN	B-VP	O
by	by	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
burning	burning	NN	I-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
,	,	,	O	O
radiates	radiate	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
shoulder	shoulder	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
sometimes	sometimes	RB	I-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
without	without	IN	B-PP	O
nausea	nausea	NN	B-NP	O
and	and	CC	O	O
occasional	occasional	JJ	B-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
negative	negative	JJ	B-NP	O
troponins	troponin	NNS	I-NP	O
and	and	CC	O	O
negative	negative	JJ	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

An	An	DT	B-NP	O
exercise	exercise	NN	I-NP	O
treadmill	treadmill	NN	I-NP	O
test	test	NN	I-NP	O
on	on	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
minutes	minute	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
maximal	maximal	JJ	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
127	127	CD	B-NP	O
and	and	CC	O	O
maximal	maximal	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
134/80	134/80	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
millimeter	millimeter	NN	I-NP	O
of	of	IN	B-PP	O
ST	ST	JJ	B-NP	O
depression	depression	NN	I-NP	O
in	in	IN	B-PP	O
V5	V5	NN	B-NP	O
and	and	CC	I-NP	O
T-wave	T-wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
V4-V6	V4-V6	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
interpreted	interpret	VBN	I-VP	O
as	as	IN	B-PP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
diagnostic	diagnostic	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
atenolol	atenolol	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
walking	walk	VBG	I-VP	O
to	to	TO	I-VP	O
catch	catch	VB	I-VP	O
a	a	DT	B-NP	O
bus	bus	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
burning	burn	VBG	B-VP	O
lasting	last	VBG	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
10	10	CD	I-NP	O
minutes	minute	NNS	I-NP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
diaphoresis	diaphoresis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
came	come	VBD	B-VP	O
by	by	IN	B-PP	O
cab	cab	NN	B-NP	B-protein
to	to	TO	B-PP	O
Rirel	Rirel	NNP	B-NP	O
Carleo	Carleo	NNP	I-NP	O
And	And	NNP	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
scheduled	scheduled	JJ	I-NP	O
exercise	exercise	NN	I-NP	O
ett/mibi	ett/mibi	NN	I-NP	O
test	test	NN	I-NP	O
study	study	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
F	F	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
V3-V6	V3-V6	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
arrival	arrival	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
pain	pain	NN	B-NP	O
free	free	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
mild	mild	JJ	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
stools	stool	NNS	B-NP	O
were	be	VBD	B-VP	O
black	black	JJ	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
iron	iron	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
29.3	29.3	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
iron	iron	JJ	B-NP	O
supplements	supplement	NNS	I-NP	O
since	since	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
colonic	colonic	JJ	B-NP	O
polyps	polyp	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
sarcoidosis	sarcoidosis	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
last	last	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
April	April	NNP	B-NP	O
1995	1995	CD	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
FEV	FEV	NN	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
1.61	1.61	CD	B-NP	O
,	,	,	O	O
72	72	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
;	;	:	O	O
FEV	FEV	CD	B-NP	O
1	1	CD	I-NP	O
ratio	ratio	NN	I-NP	O
to	to	TO	B-PP	O
FVC	FVC	NN	B-NP	O
was	be	VBD	B-VP	O
80	80	CD	B-NP	O
or	or	CC	I-NP	O
102	102	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
.	.	.	O	O

FVC	FVC	NN	B-NP	O
was	be	VBD	B-VP	O
2.01	2.01	CD	B-NP	O
or	or	CC	I-NP	O
72	72	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
and	and	CC	O	O
now	now	RB	B-VP	O
uses	use	VBZ	I-VP	O
Ventolin	Ventolin	NN	B-NP	O
inhalers	inhaler	NNS	I-NP	O
p.r.n.	p.r.n.	RB	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
seizure	seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Status	Status	NNP	I-NP	O
post	post	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
placement	placement	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
1996	1996	CD	I-NP	O
for	for	IN	B-PP	O
tachycardia	tachycardia	NN	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Status	Status	NNP	I-NP	O
post	post	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Status	Status	NNP	I-NP	O
post	post	VBD	B-VP	O
total	total	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
for	for	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Adult	Adult	NN	I-NP	O
onset	onset	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
diet-controlled	diet-controlled	JJ	B-ADJP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
calf	calf	NN	I-NP	O
deep	deep	JJ	I-NP	O
vein	vein	NN	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
colonic	colonic	JJ	B-NP	O
polyps	polyp	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
colonic	colonic	JJ	I-NP	O
adenoma	adenoma	NN	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
ADMISSION	ADMISSION	NN	B-NP	O
:	:	:	O	O
Linsinopril	Linsinopril	NNP	B-NP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Pravachol	Pravachol	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
;	;	:	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
atenolol	atenolol	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
Dilantin	Dilantin	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
Ventolin	Ventolin	NNP	B-NP	O
inhaler	inhaler	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
;	;	:	O	O
ferrous	ferrous	JJ	B-NP	O
gluconate	gluconate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
Penicillin	Penicillin	NN	B-NP	O
and	and	CC	I-NP	O
erythromycin	erythromycin	NN	I-NP	O
,	,	,	O	O
gives	give	VBZ	B-VP	O
rash	rash	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
pleasant	pleasant	JJ	I-NP	O
female	female	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
97.9	97.9	CD	B-NP	O
;	;	:	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
78	78	CD	I-NP	O
;	;	:	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
120/70	120/70	CD	I-NP	O
;	;	:	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
19	19	CD	I-NP	O
.	.	.	O	O

Saturation	Saturation	NN	B-NP	O
was	be	VBD	B-VP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

Head	Head	RB	B-ADVP	O
,	,	,	O	O
eyes	eye	NNS	B-NP	O
,	,	,	O	O
nose	nose	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
throat	throat	NN	B-NP	O
examination	examination	NN	I-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
edentulous	edentulous	JJ	I-ADJP	O
.	.	.	O	O

Jugular	Jugular	JJ	B-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
8	8	CD	B-NP	O
centimeters	centimeter	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

Carotids	Carotid	NNS	B-NP	O
were	be	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
:	:	:	O	O
Diffuse	Diffuse	NN	B-NP	O
,	,	,	O	O
dry	dry	JJ	B-NP	O
rales	rale	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

S4	S4	NN	B-NP	B-protein
present	present	JJ	B-ADJP	O
.	.	.	O	O

1/6	1/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
heard	hear	VBN	B-VP	O
at	at	IN	B-PP	O
upper	upper	JJ	B-NP	O
left	left	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Cholecystectomy	Cholecystectomy	NN	B-NP	O
scar	scar	NN	I-NP	O
.	.	.	O	O

Infraumbilical	Infraumbilical	JJ	B-NP	O
midline	midline	NN	I-NP	O
scar	scar	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Rectal	Rectal	JJ	B-ADJP	O
:	:	:	O	O
Guaiac	Guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Femoral	Femoral	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
were	be	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Dorsalis	Dorsalis	NNP	B-NP	O
pedis	pedis	NN	I-NP	O
and	and	CC	O	O
posterior	posterior	JJ	B-NP	O
tibialis	tibialis	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
were	be	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Nonfocal	Nonfocal	JJ	B-NP	O
neurological	neurological	JJ	I-NP	O
examination	examination	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
motor	motor	NN	I-NP	O
or	or	CC	O	O
sensory	sensory	JJ	B-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NN	I-NP	O
:	:	:	O	O
Bilateral	Bilateral	JJ	B-NP	O
parenchymal	parenchymal	JJ	I-NP	O
opacities	opacity	NNS	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADJP	O
prominent	prominent	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lung	lung	NN	I-NP	O
fields	field	NNS	I-NP	O
.	.	.	O	O

Stable	Stable	JJ	B-NP	O
and	and	CC	I-NP	O
consistent	consistent	JJ	I-NP	O
with	with	IN	B-PP	O
previous	previous	JJ	B-NP	O
examinations	examination	NNS	I-NP	O
from	from	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
sarcoidosis	sarcoidosis	NN	I-NP	O
.	.	.	O	O

Pacer	Pacer	NN	B-NP	O
wires	wire	NNS	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
position	position	NN	I-NP	O
.	.	.	O	O

Electrocardiogram	Electrocardiogram	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
April	April	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
66	66	CD	B-NP	O
.	.	.	O	O

T-wave	T-wave	JJ	B-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
I	I	PRP	B-NP	O
,	,	,	O	O
T-wave	T-wave	JJ	B-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
and	and	CC	O	O
AVF	AVF	NN	B-NP	B-protein
,	,	,	O	O
biphasic	biphasic	JJ	B-NP	O
T-waves	T-wave	NNS	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
T-wave	T-wave	NN	B-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
V3-V6	V3-V6	NN	B-NP	O
.	.	.	O	O

Slightly	Slightly	RB	B-ADJP	O
pronounced	pronounced	JJ	I-ADJP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
previous	previous	JJ	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
.	.	.	O	O

Sodium	Sodium	NN	B-NP	O
143	143	CD	I-NP	O
;	;	:	O	O
potassium	potassium	NN	B-NP	O
5.1	5.1	CD	I-NP	O
;	;	:	O	O
chloride	chloride	NN	B-NP	O
108	108	CD	I-NP	O
;	;	:	O	O
bicarbonate	bicarbonate	NN	B-NP	O
23	23	CD	I-NP	O
;	;	:	O	O
BUN	BUN	NN	B-NP	O
36	36	CD	I-NP	O
;	;	:	O	O
creatinine	creatinine	NN	B-NP	O
1.8	1.8	CD	I-NP	O
;	;	:	O	O
glucose	glucose	NN	B-NP	O
255	255	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
count	count	NN	I-NP	O
6700	6700	CD	I-NP	O
;	;	:	O	O
hematocrit	hematocrit	NN	B-NP	O
30.9	30.9	CD	I-NP	O
;	;	:	O	O
platelets	platelet	NNS	B-NP	B-cell_type
143	143	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
;	;	:	O	O
MCV	MCV	NN	B-NP	O
85.1	85.1	CD	I-NP	O
.	.	.	O	O

Prothrombin	Prothrombin	NN	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
11.4	11.4	CD	B-NP	O
.	.	.	O	O

Partial	Partial	JJ	B-NP	O
thromboplastin	thromboplastin	NN	I-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
25.2	25.2	CD	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
0.9	0.9	CD	B-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
was	be	VBD	B-VP	O
79	79	CD	B-NP	O
.	.	.	O	O

Troponin	Troponin	NN	B-NP	B-protein
0.0	0.0	CD	I-NP	I-protein
.	.	.	O	O

Dilantin	Dilantin	NN	B-NP	O
:	:	:	O	O
Less	Less	NN	B-NP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
29.3	29.3	CD	B-NP	O
.	.	.	O	O

Cholesterol	Cholesterol	NN	B-NP	O
total	total	NN	I-NP	O
was	be	VBD	B-VP	O
258	258	CD	B-NP	O
;	;	:	O	O
LDH	LDH	NN	B-NP	B-DNA
43	43	CD	I-NP	I-DNA
;	;	:	O	O
LDL	LDL	NN	B-NP	B-protein
166	166	CD	I-NP	I-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Talburt	Talburt	NNP	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
rule	rule	NN	I-NP	O
out	out	RP	B-PRT	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
protocol	protocol	NN	I-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
serial	serial	JJ	B-NP	O
electrocardiograms	electrocardiogram	NNS	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Nitrol	Nitrol	NN	B-NP	O
paste	paste	NN	I-NP	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
,	,	,	O	O
linsinopril	linsinopril	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
atenolol	atenolol	NN	B-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
her	her	PRP$	B-NP	O
low	low	JJ	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
ischemia	ischemia	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Stools	Stool	NNS	B-NP	O
were	be	VBD	B-VP	O
guaiac	guaiac	JJ	B-NP	O
neg	neg	NN	I-NP	O
and	and	CC	I-NP	O
anemia	anemia	NN	I-NP	O
workup	workup	NN	I-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
albuterol	albuterol	NN	I-NP	O
inhale	inhale	NN	I-NP	O
and	and	CC	I-NP	O
nebulizers	nebulizer	NNS	I-NP	O
p.r.n.	p.r.n.	VBP	B-VP	O
On	On	NNP	B-NP	O
February	February	NNP	I-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
residual	residual	JJ	I-NP	O
osteal	osteal	JJ	I-NP	O
diagonal	diagonal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
left	leave	VBD	B-VP	O
anterior	anterior	RB	I-VP	O
descending	descend	VBG	I-VP	O
stenosis	stenosis	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
stent	stent	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
diagonal	diagonal	JJ	I-NP	O
artery	artery	NN	I-NP	O
with	with	IN	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
residual	residual	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

Later	Later	RB	B-ADVP	O
than	than	IN	B-PP	O
evening	evening	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
pain	pain	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
changes	change	NNS	I-NP	O
showed	show	VBD	B-VP	O
ST	ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
in	in	IN	B-PP	O
VI	VI	CD	B-NP	O
and	and	CC	I-NP	O
VII	VII	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
T-wave	T-wave	NN	B-NP	O
more	more	RBR	B-ADJP	O
inverted	invert	VBN	I-ADJP	O
in	in	IN	B-PP	O
VIV	VIV	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
morphine	morphine	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
already	already	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
drip	drip	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
laboratory	laboratory	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
spectral	spectral	JJ	I-NP	O
study	study	NN	I-NP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
mid	mid	NN	I-NP	O
left	leave	VBD	B-VP	O
anterior	anterior	JJ	B-NP	O
descending	descend	VBG	I-NP	O
and	and	CC	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
VI	VI	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descending	NN	I-NP	O
was	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
her	her	PRP$	B-NP	O
two	two	CD	I-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterizations	catheterization	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
intermittent	intermittent	JJ	B-NP	O
atypical	atypical	JJ	I-NP	O
chest	chest	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
transient	transient	JJ	B-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
without	without	IN	B-PP	O
sustaining	sustain	VBG	B-VP	O
any	any	DT	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
CK	CK	NN	I-NP	B-protein
of	of	IN	B-PP	O
409	409	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MB	MB	NN	I-NP	B-protein
fraction	fraction	NN	I-NP	I-protein
o	o	NN	I-NP	I-protein
21	21	CD	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
had	have	VBD	B-VP	O
risen	rise	VBN	I-VP	O
to	to	TO	B-PP	O
3.1	3.1	CD	B-NP	O
,	,	,	O	O
elevated	elevate	VBN	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
1.9	1.9	CD	B-NP	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
radial	radial	JJ	B-NP	O
contrast	contrast	NN	I-NP	O
induced	induce	VBN	I-NP	O
nephrotoxicity	nephrotoxicity	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
rose	rise	VBD	B-VP	O
and	and	CC	O	O
rose	rise	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
5.1	5.1	CD	B-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	B-VP	O
began	begin	VBD	I-VP	O
to	to	TO	I-VP	O
decrease	decrease	VB	I-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
2.2	2.2	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
excellent	excellent	JJ	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
laboratories	laboratory	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
were	be	VBD	B-VP	O
a	a	DT	B-NP	O
sodium	sodium	NN	I-NP	O
of	of	IN	B-PP	O
141	141	CD	B-NP	O
;	;	:	O	O
potassium	potassium	NN	B-NP	O
4.8	4.8	CD	I-NP	O
;	;	:	O	O
chloride	chloride	NN	B-NP	O
106	106	CD	I-NP	O
;	;	:	O	O
bicarbonate	bicarbonate	NN	B-NP	O
20	20	CD	I-NP	O
;	;	:	O	O
BUN	BUN	NN	B-NP	O
31	31	CD	I-NP	O
;	;	:	O	O
creatinine	creatinine	NN	B-NP	O
2.2	2.2	CD	I-NP	O
;	;	:	O	O
glucose	glucose	NN	B-NP	O
90	90	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
count	count	NN	I-NP	O
6900	6900	CD	I-NP	O
;	;	:	O	O
hematocrit	hematocrit	NN	B-NP	O
33.9	33.9	CD	I-NP	O
;	;	:	O	O
platelets	platelet	NNS	B-NP	B-cell_type
were	be	VBD	B-VP	O
203	203	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
and	and	CC	O	O
ED	ED	JJ	B-NP	O
study	study	NN	I-NP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
essentially	essentially	RB	I-NP	O
negative	negative	JJ	I-NP	O
exercise	exercise	NN	I-NP	O
treadmill	treadmill	NN	I-NP	O
test	test	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
suboptimal	suboptimal	JJ	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
exercised	exercise	VBD	B-VP	O
for	for	IN	B-PP	O
approximately	approximately	RB	B-NP	O
five	five	CD	I-NP	O
minutes	minute	NNS	I-NP	O
on	on	IN	B-PP	O
submaximal	submaximal	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
treadmill	treadmill	NN	I-NP	O
test	test	NN	I-NP	O
protocol	protocol	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
low	low	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
included	include	VBD	B-VP	O
:	:	:	O	O
Ticlid	Ticlid	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
albuterol	albuterol	NN	B-NP	O
inhaler	inhaler	NN	I-NP	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	VBN	B-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
;	;	:	O	O
enteric-coated	enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
atenolol	atenolol	NN	B-NP	O
37.5	37.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
1/150	1/150	CD	I-NP	O
sublingual	sublingual	JJ	I-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
q.	q.	NN	I-NP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
times	time	NNS	I-NP	O
three	three	CD	B-NP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
Dilantin	Dilantin	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
followup	followup	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Doug	Doug	NNP	I-NP	O
Millis	Millis	NNP	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
office	office	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
CLEVELAND	CLEVELAND	NNP	B-NP	O
PRINCEVALLE	PRINCEVALLE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
BV49	BV49	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
COLEMAN	COLEMAN	NNP	B-NP	O
HOYLAND	HOYLAND	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
RA70	RA70	NNP	I-NP	O
XR421/0040	XR421/0040	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
09216	09216	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

VXTYRXU19	VXTYRXU19	NN	B-NP	B-protein
D	D	NN	I-NP	I-protein
:	:	:	O	O
8/18/97	8/18/97	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/30/97	3/30/97	CD	B-NP	O

